Clinical trial
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma: A Multi-center Retrospective Cohort Study in China
NCT05907772 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma: A Multi-center Retrospective Cohort Study in China
- Lead sponsor
- Zhejiang University
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 27, 2022
- Completion date
- November 10, 2022
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of liver